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Immunochemical techniques have been used extensively in studies on the chemistry 
and metabolism  of  serum  lipoproteins.  Several  investigators  (1-8) have produced 
antibodies against normal human lipoproteins by the injection of purified lipoproteins 
into rabbits, or into chickens (9). The antigen-antibody reaction between lipoproteins 
and their antisera has been demonstrated by precipitation (1-3, 5, 8), complement 
fixation (2, 3), gel diffusion (1-4, 6-8), and immuno-electrophoresis (6, 10). These in- 
vestigations  have suggested that low density and  high density lipoprotein  fractions 
axe immunologieally distinct. However, the immunologic relationships  between low 
density lipoprotein  subfractions,  the $I 3-9 and Sf  10-400 lipoproteins  (11), have 
not been completely defined, since the immunochemieal studies have been hindered by 
limitations of the procedures available for fraetionation of low density lipoproteins 
and lack of immunologic techniques sufficiently sensitive for detection of heterogeneity 
within lipoprotein  fractions  low in protein.  The immunologic specificity of Sf 3-9 
and SS 10-400 lipoprotein subfractions is important since metabolic studies have indi- 
cated a precursor-product relationship between the subfractions (12) while determina- 
tions of N terminal amino acid residues (13) have demonstrated heterogeneity of the 
protein component especially within the Sf 10-400 lipoprotein fraction. 
In the present investigation, Sf 3-9 and $I 10-400 lipoprotein fractions, pre- 
pared  by  the  dextran  sulfate-ultracentrifugal flotation procedure  of Oncley 
et  al.  (11)  and the  ultracentrifugal flotation procedure  of Hovel  et  al.  (14), 
were used to immunize rabbits. A modification of the hemagglutinafion tech- 
nique  of  Boyden  (15),  using  sheep  erythrocytes  treated  with  tannic  acid, 
"tanned" cells,  as the carrier for specific  lipoproteins, was developed for the 
immunologic investigation  of  the  low  density  lipoprotein  system.  Antisera 
were  titrated  and  cross-absorption  studies  performed  by  hemagglutination 
procedures. Precipitin ring and gel diffusion studies were included. 
Although the concentration of low density lipoproteins is elevated in athero- 
sclerosis  (16),  a  causal  relationship  between  lipoprotein  concentration  and 
atherosclerosis has not been demonstrated. It is conceivable that an elevation 
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in  low  density  lipoprotein  concentration  may  stimulate  the  production  of 
antibodies  and  that  antibodies are involved in the atherosclerotic disease proc- 
ess.  Serum  from  normal  and  atherosclerotic  subjects  was  investigated  by 
hemagglutination  procedures  for  the  presence  of  autoantibodies  against  $I 
3-9  and  $f 10-400  lipoproteins;  none,  however,  were found. 
Materials and Experimental Methods 
Preparation of Lipoproteins.--Low density Sf 3-9 and Sf 10--400 lipoproteins were isolated 
from pools of acid citrate dextrose plasma, approximately 1 liter in volume, by the dextran 
sulfate-density gradient method of Oncley, Walton, and Coruwell (11), and the flotation pro- 
cedure of Havel, Eder, and Bragdon (14). The Sj 3-9 and Sf 10--400 lipoproteins prepared by 
these methods were purified by a second ultracentrifugal flotation. In this purification scheme, 
the Sf 3-9 lipoprotein fraction was dialyzed  1 against 15 volumes of 2 ~ NaC1  ~ (density 1.078). 
Six ml. aliquots of the dialyzed lipoprotein solution were then placed in a  13.5 ml. histeroid 
centrifuge tube. The tube was filled by layering 0.15 ~ NaC1 over the lipoprotein solution and 
centrifuged at  100,000  G for  18 hours  in the Spinco model L  ultracentrifuge.  The S f  3-9 
lipoprotein fraction formed an orange-yellow band in the center of the centrifuge tube. These 
bands were separated with a tube cutter, pooled, and dialyzed against 15 volumes of 0.15 ~* 
NaCI containing no EDTA) The Sf 10-400 lipoprotein fraction was  dialyzed against  15 
volumes of 0.15 ~¢ NaCI, placed in a  13.5 ml. lusteroid centrifuge tube,  and centrifuged at 
9,300 G for 30 minutes. Chylomicrons formed a turbid layer at the top of the centrifuge tube. 
This layer was removed, the infranatant  solution placed in a  second centrifuge tube,  and 
centrifuged at 100,000  G for 18 hours.  The Sf 10-400 lipoprotein fraction formed a  turbid 
band at the top of the centrifuge tube. These bands were separated with a tube cutter, pooled, 
and dialyzed against 15 volumes of 0.15 ~  NaC1 containing no EDTA. Lipoprotein fractions 
were characterized by their nitrogen (17), phosphorus  (18), and cholesterol (19) content. 
A  high density lipoprotein fraction  (ot-lipoprotein)  and  serum free of lipoproteins were 
prepared by ultracentrifugal flotation. Serum was adjusted to density 1.21 with a NaC1-KBr 
solution (14) and centrifuged at 100,000 G for 18 hours. All serum lipoproteins floated to the 
top of the centrifuge tube where they were separated  and  pooled. The infranatant  serum 
(density 1.21) was centrifuged a second time at 100,000 G for 18 hours. Traces of lipoprotein 
were removed, the in/ranatant  serum pooled, and dialyzed against 0.15 ~  NaC1  containing 
no EDTA. This dialyzed fraction was designated as serum free of liproproteins. High density 
lipoproteins were then prepared from the pooled serum lipoproteins (supernatant  fraction). 
The supernatant solution containing all lipoproteins was dialyzed against 2 M NaC1 and 6 ml. 
aliquots placed in centrifuge tubes.  Each tube was filled  by layering 0.15  M NaC1 over the 
lipoprotein solution and centrifuged at  100,000  G for 18 hours.  The Sf 10-400 lipoproteins 
floated to the top of the tube, Sf 3-9 lipoproteins formed an orange-yellow band at the center 
of the tube, while high density lipoproteins sedimented to the bottom of the tube. The high 
density lipoprotein fraction was separated  and  adjusted  to density  1.21 with a  NaC1-KBr 
solution. Six ml. aliquots were placed in a centrifuge tube, the tube filled by layering 0.15 
NaCI over the crude high density lipoprotein fraction, and centrifuged at 100,000  G for 18 
hours. High density lipoproteins formed an orange-yellow band in the lower third of the tube 
above contaminating serum pigments and proteins, while traces of the low density lipoproteins 
1 All dialysis and centrifugation procedures were performed at 4°C. 
2 Saline solutions contained  100  rag.  per liter of the disodium salt  of ethylenediamine- 
tetraacetic acid (EDTA) adjusted to pH 7.0 -4- 0.2 with 1 ~ NaOH. 
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floated to the upper part of the centrifuge tube. The high density lipoprotein fraction was 
separated, pooled, and dialyzed against 0.15 ~  NaC1. In this isolation procedure, two cen- 
trifugation cycles were used in the separation of low density lipoproteins and other serum 
proteins from the high density lipoprotein fraction. 
Immunologic Procedures.--Nine 2 to 3 months old female rabbits (1800 to 2400 gin.) were 
selected for the preparation of antisera. Three rabbits received 1 ml. of a fresh Sf 3-9 lipo- 
protein fraction containing 0.08 rag. of protein nitrogen intravenously on alternate days for a 
series of 6 injections. Two rabbits in this group were exsanguinated 2 weeks after the last 
injection. The third rabbit received a booster injection containing 0.08 rag. protein nitrogen 
2 weeks after the original immunization series was completed. This rabbit was exsanguinated 
1 week later. A second group of 3 rabbits was immunized in the same manner with a  fresh 
S 1 10-400 lipoprotein fraction containing 0.08 mg. of protein nitrogen as the antigen. The third 
group of 3 rabbits served as a normal control. 
Tannic acid-treated erythrocytes were prepared and used to adsorb lipoprotein antigens. 
1 ml. of washed, packed sheep erythrocytes was added to 10 ml. of 1:10,000 tannic acid in 
0.15 M NaC1 and incubated for 10 minutes at 37°C. The cells were sedimented, resuspended, 
and washed 3 times in 0.15 M NaCl. The S] 3-9 and Sf 10--400 lipoproteins were diluted to the 
same protein concentration, 0.04 mg./ml., with 0.15 ~  NaC1. These protein concentrations 
correspond to 0.18 mg./ml, of the Sf 3-9 lipoproteln fraction and 0.40 mg./ml, of the S! 
10-400 lipoprotein fraction  (11). Lipoprotein concentrations were estimated from nitrogen 
analyses. Packed  "tanned" erythrocytes, 0.5 ml., were added to  10 ml. of the diluted lipo- 
protein fractions and the suspension incubated from 30 minutes to 2 hours with stirring. At 
the completion of the incubation peroid,  the cells were washed 3  times with 0.15  M NaC1 
and diluted to a 0.5 per cent suspension with a sodium chloride-phosphate buffer.  4 
Antiserum prepared from the immunization of rabbits was inactivated at  56°C.  for  30 
minutes, diluted 1:2 with 0.15 ~  NaC1,  and 1 ml. aliquots absorbed with 0.4 ml.  of washed 
packed sheep erythrocytes. The suspension was incubated at room temperature for 10 minutes 
and another 0.4 ml. volume of sheep erythrocytes added.  After an additional 10 minute in- 
cubation period, the cells were centrifuged and the supernatant serum withdrawn.  Doubling 
dilutions of the inactivated absorbed antisera were made with the sodium chloride-phosphate 
buffer  4 in a series of 15 agglutination tubes with 3 drop volumes according to the method of 
Rheins et aL  (20).  Three drops of a  0.5 per cent suspension of the "tanned" erythrocytes 
carrying either Sf 3-9 or Sf 10--400 lipoprotein fractions were added to each tube. The tubes 
were incubated at 37°C. for 30 minutes in a water bath and then examined for agglutination 
either by pattern or after a  1 minute centrifugation at 1000  R.P.M. in a  Servall angle head 
centrifuge. A diluent control was included with each experimental series. 
Immune  and normal rabbit sera  were  titrated  to  determine whether the immune sera 
displayed a  specificity for erythrocytes of different animal species.  Antisera and sera from 2 
normal rabbits were inactivated by incubation at 56°C.  for 30 minutes. Doubling dilutions of 
antisera  and  normal rabbit sera  were  made  with  the  sodium  chloride-phosphate buffer  4 
throughout a  series of 10 tubes in 3 drop volumes. Three drops of a 0.5 per cent suspension 
of washed test erythrocytes were added to each tube. All tubes, including a diluent control, 
were incubated at 37°C. for 30 minutes and examined for agglutination. 
The immunologic specificity of Sf 3-9 and Sf 10--400 antisera was determined by cross- 
absorption studies with Sf 3-9 and S¢  10-400 lipoproteins carried on  "tanned" cells.  An 
Sf 3-9 antiserum (No. 691) was inactivated, pre-absorbed with sheep erythrocytes, and diluted 
1:32 with the sodium chloride-phosphate buffer.  4 The S] 3-9 antiserum, 0.5 mi., was placed 
4 The  sodium  chloride-phosphate buffer contained  7.65  gm.  of  Na~HPOd,  1.81  gin.  of 
KH2PO4, and 8.50 gm. of NaC1 in 1 liter of deionized water (pH 7.4 -4- 0.2). 116  ~OCHEMISTRY  017  HUMAN  LOW  DENSITY LIPOPROTEINS 
in a  centrifuge tube and 0.5 ml. of packed  "tanned" erythrocytes carrying Sf 10-400 lipo- 
proteins added. This suspension was incubated from 15 to 30 minutes at 37°C., an additional 
0.5 ml. of the "tanned" ceils carrying Sf 10-400 lipoproteins added and again incubated. At 
the completion of several absorption cycles, the suspension was centrifuged and the super- 
natant  serum  removed. Aliquots of absorbed  and  unabsorbed  antisera  were then titrated 
against Sf 3-9 and S t  10-400 lipoprotein fractions by the hemagglutination procedure. The 
highest dilution in which a 4+ agglutination occurred was considered as the antibody titre 
for the antiserum. An S t  10-400 antiserum (No. 498) was absorbed with sheep erythrocytes, 
diluted 1:16 with the sodium chloride-phosphate buffer,  8 and absorbed in a similar manner 
with Sf 3-9 lipoproteins carried on "tanned" erythrocytes. The Sf 3-9 and S I  10--400 antisera 
were absorbed  with their homologous antigens carried on "tanned" erythrocytes in control 
experiments. 
The specificity of lipoprotein antisera and  the purity of lipoprotein antigens used to im- 
mnnize rabbits was confirmed by several experimental procedures. Lipoprotein antisera were 
examined  for  cross-reactivity against  antigens  consisting  of  the  high  density  lipoprotein 
fraction, albumin (Cohn V), ~,-globulins (Cohn II), and serum free of lipoproteins, by hemag- 
glutination, precipitin ring, agar diffusion plate (21), and agar diffusion  tube methods (22). 
TABLE I 
The Antibody  Titre of Ss 3-9 and S/10--400 Antisera  Titrated against Sf 3-9 and Ss 10-400 
Lipoproteins Carried on "Tanned" Erythrocytes 
Antiserum 
Anti Sf 3-9 (492) ....................... 
Anti $I 3-9 (493) ....................... 
Anti Sf 10--400 (498) .................... 
Anti Sf 10-400 (499) .................... 
Lipoproteln and titre 
st~-9 
1:4096 
1:1024 
1:512 
1:256 
st 20400 
1:512 
1:256 
1:256 
1:256 
RESULTS 
Since low density lipoprotdns vary in their  protein content,  equal amounts 
of protein  nitrogen rather than lipoprotein  were used in the immunization 
procedures. The immunization studies  revealed that an injection  of 0.08 rag. 
of protein  nitrogen from either  $I 3-9 or Sf 10-400 lipoprotein  fraction  was 
sufficient  to stimulate  antibody production in  rabbits.  This amount of  nitrogen 
corresponded to 2.3 rag.  of the Sf 3-9 lipoprotcin  fraction  or 5.0 rag.  of the Ss 
10-400 lipoprotein  fraction.  The rabbit  antisera  obtained did not react  with 
high density lipoprotdns, albumin, -/-globulins,  or lipoprotdn-frce  serum, in 
systems employing "tanned" cells,  in precipitin  ring titrations,  on agar dif- 
fusion plates,  or in agar diffusion  tubes. Hemagglutination titers  for Sj 3-9 
antisera against St 3-9 lipoproteins  carried on "tanned" cells  varied from 
1:1024 to 1:4096. 
Hemagglutination titers  for an immunization series  are recorded in Table I. 
The titer  for Sf 10-400 antisera against the Sf 10-400 lipoprotdn  fraction 
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In an experiment to test completeness of adsorption an S$ 3-9 lipoprotein fraction was ad- 
sorbed on "tanned" cells, and then the supernatant solution was withdrawn and re-adsorbed 
with "tanned" cells. A 0.5 per cent suspension of the latter cells in sodium chloride-phosphate 
buffer  4 did not hemagglutlnate upon  the addition of Sf 3-9 antiserum. The supernatant 
TABLE II 
Titration  of Sf 3--9 Antiserum,  S!  10--400 Antiserum,  and Normal  Rabbit Sera  against 
Erythroeytes of Different Blood Groups and Animal Species 
Serum 
Anti Ss 3-9 (492) 
Anti Ss 10-400 (498) 
Normal rabbit (496) 
Normal rabbit (497) 
Erythrocyte and titre 
Human 
! 
0  A  AB  I  B 
/ 
1:211:411:211:2 
1:2  1:1  1:11  0 
1:111:211:211:8 
1:111:11o  11:2 
.~'E 
1:1  [ 1:2 
1:2  0 
1:1  1:1 
1:2  I 1:1 
o~ 
1:1 
1:1 
1:1 
1:2 
1:1  1:16  1:4 
1:2  1:4  1:1 
1:1  1:2  1:1 
1:1  1:16  1:4 
1:2 
0 
1:2 
0 
TABLE III 
Cross-Abser ,tion Studies with Sy 3-9 and Sf 10-400 Antisera 
Lipoprotein  antigen  and titre 
Antiserum  Unabsorbed 
S! 3-9  I  S! 10-400 
Absorbed 
sl  ~-9  [  sl  le-4~ 
Absorption 
cyctes 
A. Titre of SI 3-9 Antiserum Before and After Absorption with S! 10-400 
Lipoproteins Carried on "Tanned" Erythrocytes 
Anti Ss 3-9 
Anti St 3-9 
Anti St 3-9 
1:512  l  1:256 
1:512  1:256 
1:256"  1:128" 
1:32  I  0  1:32  0 
1:32"  0* 
B.  Titre of S! 10-400 Antiserum before and after Absorption with S! 3-9 
Lipoproteins Carried on "Tanned" Erythrocytes 
Anti Ss 10-400 
Anti $f 10-400 
Anti Sf 10-400 
1:128 
1:512 
1:128" 
1:256 
1:256 
1:128" 
-4- 
0 
0* 
4- 
0 
0* 
* Lipoprotein fractions prepared by  the  ultracentrifugal flotation procedure of Havel 
et al. (14) and repurified. 
solution after 2 adsorption cycles gave no evidence of residual lipoprotein in agar diffusion or 
precipitin ring tests. The experiments thus indicated that the lipoprotein fraction had been 
adsorbed completely by the first group of "tanned" cells. 
The  Sf 3-9  and Sf  10-400  antisera and sera from  two  normal rabbits were 
titrated  against  erythrocytes  of  the  four  human  blood  groups  and  against 118  IMMUNOCHEMISTRY  OF  H~N  LOW  DENSITY  LIPOPROTEINS 
erythrocytes obtained from sheep, guinea pig, dog, calf, pig, horse, and chicken. 
The antisera gave no titers outside the range of normal antibodies when com- 
pared to normal rabbit serum. These results are summarized in Table II. 
The  antibody  titers  for an  Ss 3-9  antiserum  before and  after  absorption 
with  an  Sf  10-400  lipoprotein  fraction  carried  on  "tanned"  cells,  and  the 
antibody titers for an St 10-400 antiserum before and  after absorption with 
an Sj 3-9 lipoprotein fraction carried  on "tanned"  cells are recorded in Table 
III. Antibodies specific for the Ss 3-9 lipoprotein fraction remained in the Sz 
3-9 antiserum after three and four absorption cycles with Ss 10-400 lipopro- 
teins carried on "tanned"  cells. No antibodies specific for either $f 3-9 or S~, 
10-400 lipoprotein fractions remained in the SI 10-400 antiserum after three 
absorption  cycles with  an  Sf  3-9  lipoprotein  fraction  carried  on  "tanned" 
cells. The Sf 3-9  and $I 10-400 lipoprotein fractions  obtained by the ultra- 
centrifugal flotation procedure of Havel et al.  (14) reacted no differently from 
lipoprotein  fractions  prepared  by the  dextran  sulfate flotation procedure of 
Oncley et al. (11). 
Sera from 5 individuals  with no history of heart  disease and  sera from 3 
patients  with recent myocardial infarction  and  transaminase  levels  above 40 
units were titrated against an $I 3-9 lipoprotein fraction carried on "tanned" 
erythrocytes.  No  circulating  antibodies  were  demonstrated  in  the  subjects 
investigated. 
DISCUSSION 
Boyden (15) showed that  tannic acid-treated erythrocytes adsorb proteins 
from  solution  and  demonstrated  that  erythrocyte-protein  complexes  act  as 
hemagglutinins  in antigen-antibody reactions. This procedure is probably the 
most  sensitive  technique  available  for  serologic  studies  in  vitro  (23).  Low 
density lipoproteins,  high molecular weight molecules  low in protein content, 
are adsorbed from solution and react as hemagglutinins  in the same manner 
as other proteins. This fact suggests that the protein moiety is on the surface 
of the lipoprotein molecule and so is available for adsorption on the "tanned" 
erythrocyte. Although  the structure of the lipoprotein molecule  is unknown, 
the  euglobulin  solubility  (11),  combination  with  sulfated  polysaccharides 
(11),  and adsorption on  "tanned"  erythrocytes, all  support the concept of a 
protein  surface and  lipide  core.  The  structure  recently proposed by Zollner 
(24)--a lipid  surface and protein core--is not consistent with  the formation 
of lipoprotein hemagglutinins. 
The  present  investigation  confirmed  the  fact  that  the  hemagglutination 
reaction is a sensitive method for the measurement of antibody titer. It appears 
to  be  superior  to  other  immunologic  procedures  for  the  demonstration  of 
antibody specificity since  specific  antibodies  in  a  lipoprotein  antiserum  can 
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carried  on  "tanned"  erythrocytes. This  technique  also eliminates  considera- 
tion of the equivalence phenomenon since excess antigen is removed by sedi- 
mentation. Furthermore, hemagglutination is superior to quantitative precipi- 
tin  methods  for  studies  of lipoproteins  since  lipoprotein  molecules  in  the 
upper  region  of the Ss 10-400 lipoprotein spectrum are turbid, and molecules 
with a very low density, the Sf 10-400 lipoprotein fraction, may float rather 
than  sediment upon  aggregation  in  antigen-antibody  complexes  (25).  When 
Sf 10-400 antisera were absorbed with Ss 3-9 lipoproteins carried on "tanned" 
cells, all agglutinins directed against both the Sf 10-400 and Sf 3-9 lipoprotein 
fractions were removed. The data indicate that the Sf 3-9 lipoprotein fraction 
contains  the  same antigens  as  the Sf  10-400 lipoprotein  fraction.  When  SI 
3-9  antisera  were absorbed with $f 10-400 lipoproteins carried on "tanned" 
cells,  all  agglutinins  directed against  the Sf 10-400 lipoprotein fraction were 
removed,  whereas  some  agglutinins  directed  against  the  Sf 3-9  lipoprotein 
fraction remained in the antiserum.  Since low density lipoprotein antisera did 
not react with high density lipoproteins,  albumin, "r-globulins, and serum free 
of lipoproteins,  the low density lipoproteins were apparently highly purified. 
Furthermore,  the short  immunization  schedule and  immunization  with  lipo- 
proteins rather than an alum precipitate (2, 3) presumably tended to minimize 
the production of antibodies against  trace impurities.  The Ss 3-9 lipoprotein 
fraction, therefore, contained one or more antigens in addition to the antigens 
in Ss 10-400 lipoprotein, and it seems reasonable to assume that the additional 
antigenicity was lipoprotein in nature. 
Other investigators  (1, 2) have reported that S! 3-9 lipoproteins and vari- 
ous lipoprotein bands within  the Sf 10-400 lipoprotein spectrum were indis- 
tinguishable immunologically.  The present studies confirm  these observations 
and  suggest  that  lipoprotein  antigens  throughout  the Sf  10-400 lipoprotein 
spectrum are identical with lipoprotein antigens in the $I 3-9 lipoprotein frac- 
tion, although the Sf 3-9 lipoprotein fraction may contain additional antigens 
not present in the Ss 10-400 lipoprotein fraction. It should be emphasized that 
antisera directed against Ss 10-400 and Sf 3-9 lipoproteins contained no anti- 
bodies directed against  the high  density lipoprotein  fraction.  Thus,  the im- 
munologic  studies support the investigations of Gitlin et al. (12) who demon- 
strated the conversion,  in vivo, of Sf 10-400 to $f 3-9 lipoproteins.  Gitlin et al. 
(12) were unable to demonstrate the conversion of low density lipoproteins to 
high  density lipoproteins, an antigenically distinct lipoprotein fraction. 
The immunologic  specificity of the Sf 10-400 lipoprotein fraction is not con- 
sistent  with N  terminal  amino  acid  studies  (13)  in  which additional  amino 
acid end groups were demonstrated in the Ss 10-400 lipoprotein fraction. The 
discrepancy between N  terminal  amino acid studies and immunologic  studies 
may be resolved in several ways: (a)  The concentration  of some lipoprotein 
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stimulate  antibody production;  (b)  Low  density lipoproteins  isolated  from 
subjects with idiopathic hyperlipemia and used in the N  terminal amino acid 
stt~dies might have been different from the lipoproteins present in  normal 
individuals;  (c)  Lipoprotein fractions prepared  for  N  terminal  amino  acid 
analysis might have contained protein impurities. 
Antibodies prepared against the Ss 3-9 lipoprotein fraction may be used to 
detect both $1 3-9 and Sf 10-400 lipoproteins;  however, these antibodies will 
not  distinguish between the low  density lipoprotein fractions. Although an 
immunologic estimation of low density lipoproteins  has been proposed (25), 
this method will not estimate the concentration of specific low density lipo- 
protein fractions elevated in disease processes such as myxedema or nephrosis 
(12, 16).  The $f 3-9  lipoprotein fraction may be used to  detect antibodies 
against $I 3-9  and Sf  10-400 lipoproteins.  In  the present investigation,  no 
circulating antibodies against low density lipoproteins were demonstrated in 
the serum of 5 normal subjects or 3 subjects with recent myocardial infarc- 
tions by the hemagglutination of Sz 3-9 lipoproteins  carried on "tanned" cells. 
SUMMARY 
IIemagglutination is a specific and sensitive  technique for investigating the 
purity of lipoproteins  and the immunologic relationships between low density 
lipoprotein fractions. 
The $I 10-400 and Sf 3-9 lipoprotein fractions, isolated from human serum 
by dextran sulfate-density gradient centrffugation procedure and  repurified 
by centrifugation appeared to  contain only lipoprotein antigens since  these 
fractions did not stimulate the production of antibodies against other serum 
proteins. Cross-absorption  experiments with lipoproteins  carried on "tanned" 
cells demonstrated that the Sf 3-9 lipoprotein fraction contains all  the anti- 
genic components of the Sf 10-400 lipoprotein fraction together with additional 
antigenic components not found in the Sj 10400  lipoprotein fraction. Thus 
$f 3-9 and Sf 10-400 lipoprotein fractions are immunologically similar but not 
identical. Low density lipoproteins  contain no antigens in common with the 
high density lipoproteins. 
An Sj 3-9 antiserum can be used to detect both Sf 3-9 and Sz 10-400 anti- 
gens. The Sf 3-9 lipoprotein fraction used as an antigen will detect antibodies 
against both Sf 3-9 and Sf 10-400 lipoprotein fractions. The Ss 3-9 and SI 
10-400 antisera did not  contain immune antibodies against erythrocytes of 
the different blood groups or against sheep,  guinea pig,  dog, calf, pig,  horse, 
and chicken erythrocytes. 
Normal subjects and subjects with recent myocardial infarctions had no 
circulating autoantibodies against the Sf 3-9 and $f 10-400 lipoprotein frac- 
tions. W.  W.  BRI/CER~ ~.  W.  RIDDLE~  AND  D.  G.  CORI'~VELL  121 
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